Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 5
1997 26
1998 34
1999 44
2000 53
2001 39
2002 50
2003 56
2004 57
2005 52
2006 54
2007 42
2008 36
2009 37
2010 20
2011 17
2012 24
2013 19
2014 19
2015 14
2016 22
2017 26
2018 19
2019 16
2020 24
2021 33
2022 23
2023 29
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

822 results

Results by year

Filters applied: . Clear all
Page 1
Novel ZFTA::NCOA1 fusion in chondroid lipoma.
Zilla ML, Marker DF, John I. Zilla ML, et al. Histopathology. 2023 May;82(6):956-958. doi: 10.1111/his.14879. Epub 2023 Feb 21. Histopathology. 2023. PMID: 36734585 No abstract available.
The NCOA1-CBP-NF-kappaB transcriptional complex induces inflammation response and triggers endotoxin-induced myocardial dysfunction.
Peng Q, Hua Y, Xu H, Chen X, Xu H, Wang L, Zhao H. Peng Q, et al. Exp Cell Res. 2022 Jun 15;415(2):113114. doi: 10.1016/j.yexcr.2022.113114. Epub 2022 Mar 24. Exp Cell Res. 2022. PMID: 35339471
LPS treatment also inhibited DNMT1 (DNA methyltransferase 1) expression, thereby decreasing DNA methylation of a CpG island located on the promoter of NCOA1 and causing NCOA1 overexpression. Screening small molecules that abolished NCOA1-CBP interaction in a …
LPS treatment also inhibited DNMT1 (DNA methyltransferase 1) expression, thereby decreasing DNA methylation of a CpG island located on the p …
NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
Qin L, Wu YL, Toneff MJ, Li D, Liao L, Gao X, Bane FT, Tien JC, Xu Y, Feng Z, Yang Z, Xu Y, Theissen SM, Li Y, Young L, Xu J. Qin L, et al. Cancer Res. 2014 Jul 1;74(13):3477-88. doi: 10.1158/0008-5472.CAN-13-2639. Epub 2014 Apr 25. Cancer Res. 2014. PMID: 24769444 Free PMC article.
To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 transgenic [Tg(NCOA1)] mice. ...However, NCOA1 overexpression increased the number of circulating breast cancer cells and the …
To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 …
NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1alpha- and AP-1-mediated VEGFa transcription.
Qin L, Xu Y, Xu Y, Ma G, Liao L, Wu Y, Li Y, Wang X, Wang X, Jiang J, Wang J, Xu J. Qin L, et al. Oncotarget. 2015 Sep 15;6(27):23890-904. doi: 10.18632/oncotarget.4341. Oncotarget. 2015. PMID: 26287601 Free PMC article.
In this study, we found that the microvascular density (MVD) was significantly decreased and increased in Ncoa1-knockout and NCOA1-overexpressing mammary tumors, respectively, in several breast cancer mouse models. ...In 140 human breast tumors, high NCOA1 pr …
In this study, we found that the microvascular density (MVD) was significantly decreased and increased in Ncoa1-knockout and NCOA1 …
PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm.
Lacambra MD, Weinreb I, Demicco EG, Chow C, Sung YS, Swanson D, To KF, Wong KC, Antonescu CR, Dickson BC. Lacambra MD, et al. Genes Chromosomes Cancer. 2019 Oct;58(10):705-712. doi: 10.1002/gcc.22762. Epub 2019 Apr 30. Genes Chromosomes Cancer. 2019. PMID: 31008539 Free PMC article.
Following identification of two index cases of a distinctive fibroblastic neoplasm with a fusion gene involving PRRX1 and NCOA1, we performed a retrospective review to further characterize this entity. ...
Following identification of two index cases of a distinctive fibroblastic neoplasm with a fusion gene involving PRRX1 and NCOA1, we p …
NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
Lu B, Xia Y, Chen J, Tang J, Shao Y, Yu W. Lu B, et al. Hum Pathol. 2023 May;135:65-75. doi: 10.1016/j.humpath.2023.01.001. Epub 2023 Jan 13. Hum Pathol. 2023. PMID: 36646185
Recurrent NCOA1/2/3 gene fusions emerged in uterine tumor resembling ovarian sex cord tumor (UTROSCT). ...Fluorescence in situ hybridization for dual color break-apart probes of NCOA1, NCOA2, NCOA3, BCOR, YWHAE, PHF1 and JAZF1 were performed on 16 tumors. ...
Recurrent NCOA1/2/3 gene fusions emerged in uterine tumor resembling ovarian sex cord tumor (UTROSCT). ...Fluorescence in situ hybrid …
The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1.
Luef B, Handle F, Kharaishvili G, Hager M, Rainer J, Janetschek G, Hruby S, Englberger C, Bouchal J, Santer FR, Culig Z. Luef B, et al. Endocr Relat Cancer. 2016 Jun;23(6):495-508. doi: 10.1530/ERC-16-0160. Epub 2016 Jun 2. Endocr Relat Cancer. 2016. PMID: 27255895
Protein kinase D1 (PRKD1) was found to be prominently up-regulated by NCOA1 knockdown in MDA PCa 2b, but not in PC3 cells. Inhibition of PRKD1 reverted the reduced migratory potential caused by NCOA1 knockdown. ...Thus, our findings directly associate the AR/NCOA …
Protein kinase D1 (PRKD1) was found to be prominently up-regulated by NCOA1 knockdown in MDA PCa 2b, but not in PC3 cells. Inhibition …
Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking.
Zhang W, Tian W, Wang Y, Jin X, Guo H, Wang Y, Tang Y, Yao X. Zhang W, et al. Comput Biol Med. 2022 Dec;151(Pt A):106293. doi: 10.1016/j.compbiomed.2022.106293. Epub 2022 Nov 10. Comput Biol Med. 2022. PMID: 36399857 Free article.
The target with a higher degree were identified through the PPI network, namely AR, RELA, NCOA1, EGFR, FOS, CCND1, ESR1 and HSP90AA1. GO and KEGG analysis suggested that MFXD treatment of lung cancer mainly involves hormone and response to inorganic substance, transcriptio …
The target with a higher degree were identified through the PPI network, namely AR, RELA, NCOA1, EGFR, FOS, CCND1, ESR1 and HSP90AA1. …
Targeted Inhibition of the NCOA1/STAT6 Protein-Protein Interaction.
Lee Y, Yoon H, Hwang SM, Shin MK, Lee JH, Oh M, Im SH, Song J, Lim HS. Lee Y, et al. J Am Chem Soc. 2017 Nov 15;139(45):16056-16059. doi: 10.1021/jacs.7b08972. Epub 2017 Nov 1. J Am Chem Soc. 2017. PMID: 29090910
We demonstrate that this stapled peptide disrupts the NCOA1/STAT6 complex, thereby repressing STAT6-mediated transcription. Furthermore, we solved the first crystal structure of a stapled peptide in complex with NCOA1. The stapled peptide therefore represents an inv …
We demonstrate that this stapled peptide disrupts the NCOA1/STAT6 complex, thereby repressing STAT6-mediated transcription. Furthermo …
Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.
Huang SC, Ghossein RA, Bishop JA, Zhang L, Chen TC, Huang HY, Antonescu CR. Huang SC, et al. Am J Surg Pathol. 2016 Jan;40(1):51-9. doi: 10.1097/PAS.0000000000000492. Am J Surg Pathol. 2016. PMID: 26371783 Free PMC article.
Novel PAX3-NCOA1 fusions were identified in these 2 index cases showing an inv(2)(q35p23) by FISH and confirmed by reverse transcription polymerase chain reaction. ...In conclusion, we report a novel PAX3-NCOA1 fusion in BSNS, which appears to be associated with foc …
Novel PAX3-NCOA1 fusions were identified in these 2 index cases showing an inv(2)(q35p23) by FISH and confirmed by reverse transcript …
822 results